Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 5Interventional 5

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 2234Neoplasms 2039Lung Neoplasms 1097Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 674Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 347Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Observational × Immunotherapy × Clear all
NCT05909137 2025-07-14

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Xinqiao Hospital of Chongqing

Not yet recruiting
60 enrolled
Thoracic

Immunotherapy

NCT06946745 2025-04-27

Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Recruiting
50 enrolled

Immunotherapy

NCT06276088 2024-03-15

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Nanfang Hospital, Southern Medical University

Recruiting
374 enrolled

Immunotherapy

NCT05719324 2023-02-10

Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study

The First Affiliated Hospital with Nanjing Medical University

Unknown
200 enrolled

Immunotherapy

NCT04587817 2020-10-14

Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors

Peking University First Hospital

Unknown
60 enrolled

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡